Shinya_Kimura

Nobel Laureate Abel Laureate Advisory Board Member USERN President USERN Policy Making Council USERN Manager USERN Deputy Junior Ambassador

Major: Clinical Medicine

Field: Hematology

Resume

Education

1980-1986 Jichi Medical School, Japan
1996-1998 Postdoctoral Fellow, Division of Cancer and Haematology, The Walter andEliza Hall Institute, Australia
2000-2001 Postdoctoral Fellow, Dep. of Haematology, Frankfurt University, Germany

Employment Experience

2002-2009 Assistant Professor, Dep. Transfusion Medicine and Cell Therapy, Kyoto University Hospital
2009-present Professor and Chairman, Division of Hematology, Respiratory Medicine and Oncology, Faculty of Medicine, Saga University
2010-2016 Director, Cancer Center, Saga University Hospital
2014-present Vice President, Saga University Hospital
2017-present Professor, Dep. Drug Discovery and Biomedical Sciences (Serve concurrently as above)

Field of Specialization

Hematology, General pharmacology

Research Topics and Results

Original Articles

Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease;　2020/12 ANNOUNCEMENT INFO.;　BMC Pulm Med , 20, 1, 318 AUTHOR;　○Hiroki Tashiro, Yuki Kurihara, Koichiro Takahashi, Hironori Sadamatsu, Tetsuro Haraguchi, Ryo Tajiri, Ayako Takamori, Shinya Kimura, Naoko Sueoka-Aragane
Monitoring of tumor cells by flow cytometry permits rapid evaluation of disease progression in monomorphic epitheliotropic intestinal T-cell lymphoma ;　2020/12 ANNOUNCEMENT INFO.;　Cytometry B Clin Cytom AUTHOR;　○Akihisa Umino, Yasushi Kubota, Miho Honda-Yoshigai, Tomomi Okazaki, Yurie Yoshihara, Kazuo Wakayama, Seiji Kawasaki, Kana Kusaba, Shinya Kimura, Eisaburo Sueoka
Clinical Manifestations of Allergic Bronchopulmonary Aspergillosis without Major Features of Asthma Diagnosed by the New Criteria in Japan;　2020/11 ANNOUNCEMENT INFO.;　Intern Med AUTHOR;　Yuki Kurihara, Hiroki Tashiro, Koichiro Takahashi, Natsuko Komiya, Hironori Sadamatsu, Shinya Kimura, Naoko Sueoka-Aragane
Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia;　2020/11 ANNOUNCEMENT INFO.;　Turk J Haematol AUTHOR;　Keisuke Kidoguchi, Yasushi Kubato, Yuki Nishimura, Haruna Kizuka-Sano, Shinya Kimura
HLA polymorphisms are associated with treatment-free remission following discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia;　2020/10 ANNOUNCEMENT INFO.;　Mol Cancer Ther AUTHOR;　Hiroshi Ureshino, Takero Shindo, Hidenori Tanaka, Hiroh Saji, Shinya Kimura
Biomarkers for Overweight in Adult-Onset Asthma;　2020/10 ANNOUNCEMENT INFO.;　J Asthma Allergy, 13, 409-414 AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Hironori Sadamatsu, Yuki Kurihara, Tetsuro Haraguchi, Ryo Tajiri, Ayako Takamori, Shinya Kimura, Naoko Sueoka-Aragane
A methotrexate-associated lymphoproliferative disorder expressing CD10 and BCL6 with the IGH/CCND1 translocation;　2020/10 ANNOUNCEMENT INFO.;　Ann Hematol, 99, 10, 2449-2451 AUTHOR;　Hiroo Katsuya, Haruna Kizuka-Sano, Masako Yokoo, Keisuke Kidoguchi, Kyosuke Yamaguchi, Atsujiro Nishioka, Hiroshi Ureshino, Yasushi Kubota, Toshihiko Ando, Shinji Naito, Koichi Ohshima, Shinya Kimura
Evaluation of olfactory dysfunction to estimate the presence of eosinophilic chronic rhinosinusitis in patients with asthma;　2020/09 ANNOUNCEMENT INFO.;　Respir Investig AUTHOR;　Koichiro Takahashi, Hironori Sadamatsu, Kumiko Suzuki, Hiroki Tashiro, Shinya Kimura, Yuichiro Kuratomi, Naoko Sueoka-Aragane
First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease;　2020/09 ANNOUNCEMENT INFO.;　Int J Chron Obstruct Pulmon Dis, 15, 2115-2126 AUTHOR;　Koichiro Takahashi, Masaru Uchida, Go Kato, Ayako Takamori, Takashi Kinoshita, Makoto Yoshida, Ryo Tajiri, Keisuke Kojima, Hiroshi Inoue, Hiromi Kobayashi, Hironori Sadamatsu, Hiroki Tashiro, Masahide Tanaka, Shinichiro Hayashi, Atsushi Kawaguchi, Shinya Kimura, Naoko Sueoka-Aragane, Tomotaka Kawayama, Saga-naïve COPD Physical Activity Evaluation (SCOPE) Study Investigator Group
Efficacy of dupilumab and biomarkers for systemic corticosteroid naïve allergic bronchopulmonary mycosis;　2020/09 ANNOUNCEMENT INFO.;　Allergol Int AUTHOR;　○Hiroki Tashiro, Koichiro Takahashi, Yuki Kurihara, Hironori Sadamatsu, Shinya Kimura, Naoko Sueoka-Aragane
Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis using the new oral demethylating agent OR-2100;　2020/08 ANNOUNCEMENT INFO.;　Blood, 136, 7, 871-884 AUTHOR;　○Tatsuro Watanabe, Satoshi Yamashita, Hiroshi Ureshino, Kazuharu Kamachi, Yuki Kurahashi, Yuki Fukuda-Kurahashi, Nao Yoshida, Naoko Hattori, Hideaki Nakamura, Akemi Sato, Atsushi Kawaguchi, Naoko Sueoka-Aragane, Kensuke Kojima, Seiji Okada, Toshikazu Ushijima, Shinya Kimura, Eisaburo Sueoka
Naked antisense double-stranded DNA oligonucleotide efficiently suppresses BCR-ABL positive leukemic cells;　2020/08 ANNOUNCEMENT INFO.;　Invest New Drugs, 38, 4, 1012-1019 AUTHOR;　Toshimi Hoshiko, Yasushi Kubota, Takuya Akisawa, Tatsuro Watanabe, Kazuaki Tanigawara, Junichi Yano, Shinya Kimura
Allelic polymorphisms of KIRs and antitumor immunity against chronic myeloid leukemia;　2020/07 ANNOUNCEMENT INFO.;　Immunol Med AUTHOR;　*Takero Shindo, Hiroshi Ureshino, Hiroto Kojima, Hidenori Tanaka, Shinya Kimura
Surrogate Markers for Treatment-Free Remission in Patients With Chronic Myeloid Leukemia;　2020/07 ANNOUNCEMENT INFO.;　Clin Lymphoma Myeloma Leuk AUTHOR;　Hiroshi Ureshino, Kazuharu Kamachi, Shinya Kimura
J-SKI will be able to elucidate whether the renal function recover or not after discontinuation of tyrosine kinase inhibitors;　2020/07 ANNOUNCEMENT INFO.;　Int J Hematol AUTHOR;　Sho Okamoto, Hiroshi Ureshino, Shinya Kimura
Origin of circulating free DNA in patients with lung cancer;　2020/07 ANNOUNCEMENT INFO.;　PLoS One, 15, 7, e0235611 AUTHOR;　○Tomonori Abe, Chiho Nakashima, Akemi Sato, Yohei Harada, Eisaburo Sueoka, Shinya Kimura, Atsushi Kawaguchi, Naoko Sueoka-Aragane
Assessment of estimated glomerular filtration rate in patients with chronic myeloid leukemia following discontinuation of tyrosine kinase inhibitors;　2020/07 ANNOUNCEMENT INFO.;　Int J Hematol, 112, 1, 41-45 AUTHOR;　Sho Okamoto, Hiroshi Ureshino, Atsushi Kawaguchi, Motoaki Miyazono, Yuji Ikeda, Shinya Kimura
Pharmacokinetics of dasatinib in a hemodialysis patient with chronic myeloid leukemia and chronic kidney disease;　2020/07 ANNOUNCEMENT INFO.;　Int J Hematol, 112, 1, 115-117 AUTHOR;　*Jinichi Mori, Kumi Oshima, Tetsuya Tanimoto, Hikari Ishizuka, Shinya Kimura, Masatomo Miura, Naoto Takahashi
Accelerated Phase of Atypical Chronic Myeloid Leukemia with Severe Disseminated Intravascular Coagulation at Initial Presentation;　2020/06 ANNOUNCEMENT INFO.;　Intern Med, 59, 12, 1549-1553 AUTHOR;　Mai Fujita, Kazuharu Kamachi, Masako Yokoo, Keisuke Kidoguchi, Kana Kusaba, Haruna Kizuka-Sano, Kyosuke Yamaguchi, Atsujiro Nishioka, Mariko Yoshimura, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Shinya Kimura
Successful Anti-TNF-Alpha Therapy for Crohn's Disease After Allogeneic Stem Cell Transplantation: A Case Report;　2020/06 ANNOUNCEMENT INFO.;　Tohoku J Exp Med, 251, 2, 81-85 AUTHOR;　Kazuharu Kamachi, Toshihiko Ando, Nanae Tsuruoka, Mariko Hashiguchi, Keisuke Kidoguchi, Kana Kusaba, Haruna Sano, Haruhiko Sano, Kyosuke Yamaguchi, Atsujiro Nishioka, Mariko Yoshimura, Masako Yokoo, Yasushi Kubota, Kensuke Kojima, Shinya Kimura
Does patient sex play a role in treatment-free remission in chronic myeloid leukemia?;　2020/06 ANNOUNCEMENT INFO.;　Int J Hematol, 111, 6, 903 AUTHOR;　Hiroshi Ureshino, Kazuharu Kamachi, Shinya Kimura
Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy;　2020/06 ANNOUNCEMENT INFO.;　Int J Hematol, 111, 6, 897-902 AUTHOR;　Hiroshi Ureshino, Shuichi Koarada, Kazuharu Kamachi, Mariko Yoshimura, Masako Yokoo, Yasushi Kubota, Toshihiko Ando, Tatsuo Ichinohe, Tomohiro Morio, Shinya Kimura
Development of an application for management of drug holidays in perioperative periods;　2020/05 ANNOUNCEMENT INFO.;　Medicine (Baltimore), 99, 19, e20142 AUTHOR;　○Sakiko Kimura, Akiko Emoto, Mariko Yoshimura, Kota Arimizu, Tomoko Kamura, Rintaro Sogawa, Kikumi Mizuta, Yasuhiro Tagomori, Masahiro Natsuaki, Masataka Kajiwara, Nanae Tsuruoka, Yusuke Yakushiji, Yoshinori Tanigawa, Chihiro Takamatsu, Atsushi Danjo, Keiji Kamohara, Naomi Hirakawa, Yoshiro Sakaguchi, Mitsuru Noguchi, Hirokazu Noshiro, Atsushi Kawaguchi, Eisaburo Sueoka, Yutaka Narisawa, Shinya Kimura
Reconstitution of NK cells expressing KIR3DL1 is associated with reduced NK cell activity and relapse of CML after allogeneic hematopoietic stem cell transplantation;　2020/05 ANNOUNCEMENT INFO.;　Int J Hematol, 111, 5, 733-738 AUTHOR;　Hiroshi Ureshino, Takero Shindo, Haruhiko Sano, Yasushi Kubota, Toshihiko Ando, Keisuke Kidoguchi, Kana Kusaba, Hidekazu Itamura, Hiroto Kojima, Yasushi Kusunoki, Yuki Miyazaki, Kensuke Kojima, Hidenori Tanaka, Hiroh Saji, Koichi Oshima, Shinya Kimura
Clinical impact of advanced chronic kidney disease in patients with non-HIV pulmonary cryptococcosis;　2020/04 ANNOUNCEMENT INFO.;　BMC Pulm Med, 20, 1, 116 AUTHOR;　○Hiroki Tashiro, Tetsuro Haraguchi, Koichiro Takahashi, Hironori Sadamatsu, Ryo Tajiri, Ayako Takamori, Shinya Kimura, Naoko Sueoka-Aragane
Budget impact analysis of treatment-free remission in nilotinib-treated Japanese chronic myeloid leukemia patients;　2020/04 ANNOUNCEMENT INFO.;　Cancer Sci AUTHOR;　*Kiyotaka Yamazaki, Naohito Inagaki, Daniel Moldaver, Ricardo Viana, Shinya Kimura
Terminal deoxynucleotidyl transferase (TdT) negative early T cell precursor acute lymphoblastic leukemia (ETP-ALL) with spontaneous acute kidney injury;　2020/04 ANNOUNCEMENT INFO.;　Ann Hematol, 99, 4, 885-886 AUTHOR;　Keisuke Kidoguchi, Masako Yokoo, Akihisa Umino, Shigehisa Aoki, Shinya Kimura
Durable remission of post-transplant relapsed FLT3-ITD AML in response to gilteritinib administration after a second transplant from the same donor;　2020/03 ANNOUNCEMENT INFO.;　Int J Hematol AUTHOR;　Toshihiko Ando, Haruna Sano, Masako Yokoo, Kana Kusaba, Keisuke Kidoguchi, Kyosuke Yamaguchi, Hiroo Katsuya, Satoshi Yoshihara, Yasushi Kubota, Kensuke Kojima, Shinya Kimura
Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial;　2020/03 ANNOUNCEMENT INFO.;　Lancet Haematol, 7, 3, e218-e225 AUTHOR;　Shinya Kimura, Jun Imagawa, Kazunori Murai, Masayuki Hino, Toshio Kitawaki, Masaya Okada, Hideo Tanaka, Motohiro Shindo, Takashi Kumagai, Takayuki Ikezoe, Nobuhiko Uoshima, Tsutomu Sato, Reiko Watanabe, Shugo Kowata, Masaya Hayakawa, Takaaki Hosoki, Kazuhiko Ikeda, Tsutomu Kobayashi, Yasutaka Kakinoki, Tetsuo Nishimoto, Naoki Takezako, Hirohiko Shibayama, Akifumi Takaori-Kondo, Hirohisa Nakamae, Atsushi Kawaguchi, Hiroshi Ureshino, Junichi Sakamoto, Yoji Ishida, DADI Trial Group
Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation;　2020/02 ANNOUNCEMENT INFO.;　Blood Adv, 4, 4, 667-671 AUTHOR;　Hidekazu Itamura, Takero Shindo, Satoshi Yoshioka, Takayuki Ishikawa, Shinya Kimura
Clinical impact of the CONUT score in patients with multiple myeloma;　2020/01 ANNOUNCEMENT INFO.;　Ann Hematol, 99, 1, 113-119 AUTHOR;　Sho Okamoto, Hiroshi Ureshino, Keisuke Kidoguchi, Kana Kusaba, Haruna Kizuka-Sano, Haruhiko Sano, Atsujiro Nishioka, Kyosuke Yamaguchi, Kazuharu Kamachi, Hidekazu Itamura, Mariko Yoshimura, Masako Yokoo, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Atsushi Kawaguchi, Eisaburo Sueoka, Shinya Kimura
Role of cancer immunology in chronic myelogenous leukemia;　2020/01 ANNOUNCEMENT INFO.;　Leuk Res, 88, 106273 AUTHOR;　Hiroshi Ureshino, Takero Shindo, Shinya Kimura
The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model;　2020/01 ANNOUNCEMENT INFO.;　Inflamm Res. , 69, 1, 139-151 AUTHOR;　Sadamatsu H, Takahashi K, Tashiro H, Kato G, Noguchi Y, Kurata K, Ōmura S, Kimura S, Sunazuka T, Sueoka-Aragane N
Concomitant Nephrotic Syndrome with Diffuse Large B-cell Lymphoma: A Case Report;　2020 ANNOUNCEMENT INFO.;　Tohoku J Exp Med, 252, 2, 153-157 AUTHOR;　Keisuke Kidoguchi, Hiroo Katsuya, Hiroshi Ureshino, Haruna Kizuka-Sano, Kyosuke Yamaguchi, Ayako Nagata, Shuichi Rikitake, Kanako Aikawa, Shinji Naito, Shigehisa Aoki, Yasushi Kubota, Toshihiko Ando, Shinya Kimura
The Nonantibiotic Macrolide EM900 Attenuates House Dust Mite-Induced Airway Inflammation in a Mouse Model of Obesity-Associated Asthma;　2020 ANNOUNCEMENT INFO.;　Int Arch Allergy Immunol, 181, 9, 665-674 AUTHOR;　○Hironori Sadamatsu, Koichiro Takahashi, Hiroki Tashiro, Yuki Kurihara, Go Kato, Masaru Uchida, Yoshihiko Noguchi, Keigo Kurata, Satoshi Ōmura, Toshiaki Sunazuka, Shinya Kimura, Naoko Sueoka-Aragane
Association of Genetic Polymorphisms With Afatinib-induced Diarrhoea;　2020 ANNOUNCEMENT INFO.;　In Vivo, 34, 3, 1415-1419 AUTHOR;　Rintaro Sogawa, Chiho Nakashima, Tomomi Nakamura, Koji Takeuchi, Sakiko Kimura, Kazutoshi Komiya, Yutaka Narisawa, Shinya Kimura, Naoko Sueoka-Aragane
POSITIVE RATE OF BLOOD PRODUCTS IN THE IRREGULAR ANTIBODY SCREENING TEST AND THE SIGNIFICANCE OF MINOR CROSSMATCHING IN THE CROSSMATCH TEST;　2019/12 ANNOUNCEMENT INFO.;　, 65, 6, 865-869 AUTHOR;　Marie Yamada, Naotomo Yamada, Mami Nakao, Yasushi Kubota, Shinya Kimura, Eisaburo Sueoka
Immunohistochemical localization of afatinib in male rat intestines and skin after its oral administration;　2019/11 ANNOUNCEMENT INFO.;　Acta Histochem, 121, 8, 151439 AUTHOR;　*Yutaro Yamamoto, Tetsuya Saita, Yuta Yamamoto, Rintaro Sogawa, Sakiko Kimura, Yutaka Narisawa, Shinya Kimura, Masashi Shin
Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia.;　2019/11 ANNOUNCEMENT INFO.;　Int J Hematol. , 110, 5, 566-574 AUTHOR;　＊Sakaguchi M, Yamaguchi H, Kuboyama M, Najima Y, Usuki K, Ueki T, Oh I, Mori S, Kawata E, Uoshima N, Kobayashi Y, Kako S, Tajika K, Shono K, Kayamori K, Hagihara M, Kanda J, Uchiyama H, Kuroda J, Uchida N, Kubota Y, Kimura S, Kurosawa S, Date K, Nakajima N, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Wakita S, Arai K, Kitano T, Kakihana K, Kanda Y, Ohashi K, Fukuda T, Inokuchi K.
Japan's high-cost medical expense benefit system could be an obstacle to promoting generic imatinib;　2019/10 ANNOUNCEMENT INFO.;　Lancet Haematol, 6, 10, e498 AUTHOR;　Hiroshi Ureshino, Kazuharu Kamachi, Shinya Kimura
Naked antisense double-stranded DNA oligonucleotide efficiently suppresses BCR-ABL positive leukemic cells.;　2019/10 ANNOUNCEMENT INFO.;　Invest New Drugs, 38, 4, 1012-1019 AUTHOR;　Hoshiko T, Kubota Y, Akisawa T, Watanabe T, Tanigawara K, Yano J, Kimura S.
Discontinuation due to immune-related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non-small cell lung cancer.;　2019/09 ANNOUNCEMENT INFO.;　Thorac Cancer. , 10, 9, 1798-1804 AUTHOR;　Komiya K, Nakamura T, Abe T, Ogusu S, Nakashima C, Takahashi K, Kimura S, Sueoka-Aragane N
Assessment of tumor volume and density as a measure of the response of advanced hepatocellular carcinoma to sorafenib: Application of automated measurements on computed tomography scans;　2019/08 ANNOUNCEMENT INFO.;　JGH Open, 4, 2, 145-152 AUTHOR;　*Junta Yamamichi, Yasunori Kawaguchi, Taiga Otsuka, Shunya Nakashita, Hideaki Mizobe , Yuichiro Eguchi, Shinya Kimura
Locally distributed multicentric plasmacytomas in the ileum secondary to lymphoma chemoimmunotherapy;　2019/06 ANNOUNCEMENT INFO.;　Ann Hematol, 98, 6, 1501-1503 AUTHOR;　Masako Yokoo, Kensuke Kojima, Haruna Sano, Keita Kai, Fumiko Arakawa, Koichi Ohshima, Taketo Matsunaga, Shinya Kimura
HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia;　2019/06 ANNOUNCEMENT INFO.;　Leukemia, 33, 6, 1439-1450 AUTHOR;　*Jong-Ho Park, Young Min Woo, Emilia Moonkyung Youm, Nada Hamad, Hong-Hee Won, Kazuhito Naka, Eun-Ju Park, June-Hee Park, Hee-Jin Kim, Sun-Hee Kim, Hyeoung-Joon Kim, Jae Sook Ahn, Sang Kyun Sohn, Joon Ho Moon, Chul Won Jung, Silvia Park, Jeffrey H Lipton, Shinya Kimura, Jong-Won Kim, Dennis Dong Hwan Kim
Mogamulizumab for the Treatment of Adult T-cell Leukemia/Lymphoma;　2019/06 ANNOUNCEMENT INFO.;　Clin Lymphoma Myeloma Leuk, 19, 6, 326-331 AUTHOR;　Hiroshi Ureshino, Kazuharu Kamachi, Shinya Kimura
Oral ulceration: an unusual manifestation of lymphomatoid granulomatosis;　2019/05 ANNOUNCEMENT INFO.;　Ann Hematol, 98, 5, 1305-1307 AUTHOR;　Keisuke Kidoguchi, Mariko Yoshimura, Kensuke Kojima, Hiroshi Ureshino, Ryoko Egashira, Masako Yokoo, Keita Kai, Yoshiaki Egashira, Koichi Ohshima, Toshihiko Ando, Shinya Kimura
Development of a sandwich enzyme-linked immunosorbent assay for the quantification of ponatinib in serum;　2019/04 ANNOUNCEMENT INFO.;　Anal Biochem, 571, 14-20 AUTHOR;　*Yuta Yamamoto, Tetsuya Saita, Rintaro Sogawa, Kenji Ogata, Yutaro Yamamoto, Sakiko Kimura, Yutaka Narisawa, Shinya Kimura, Masashi Shin
Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial);　2019/04 ANNOUNCEMENT INFO.;　Int J Clin Oncol, 24, 4, 445-453 AUTHOR;　*Shin Fujisawa, Yasunori Ueda, Kensuke Usuki, Hajime Kobayashi, Eisei Kondo, Noriko Doki, Takafumi Nakao, Yoshinobu Kanda, Nobuharu Kosugi, Hiroshi Kosugi, Takashi Kumagai, Hiroshi Harada, Masato Shikami, Yasuhiro Maeda, Toru Sakura, Koiti Inokuchi, Akio Saito, Yuichiro Nawa, Masahiro Ogasawara, Junji Nishida, Takeshi Kondo, Chikashi Yoshida, Hiroyuki Kuroda, Yoko Tabe, Yoshinobu Maeda, Kenji Imajo, Kensuke Kojima, Satoshi Morita, Sho Komukai, Atsushi Kawaguchi, Junichi Sakamoto, Shinya Kimura
A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib;　2019/03 ANNOUNCEMENT INFO.;　PLoS One, 14, 3, e0207170 AUTHOR;　Hiroaki Kitamura, Yoko Tabe, Tomohiko Ai, Koji Tsuchiya, Maiko Yuri, Shigeki Misawa, Takashi Horii, Atsushi Kawaguchi, Akimichi Ohsaka, Shinya Kimura
C/EBPβ is a critical mediator of IFN-α-induced exhaustion of chronic myeloid leukemia stem cells;　2019/02 ANNOUNCEMENT INFO.;　Blood Adv, 3, 3, 476-488 AUTHOR;　*Asumi Yokota, Hideyo Hirai, Ryuichi Sato, Hiroko Adachi, Fumiko Sato, Yoshihiro Hayashi , Atsushi Sato, Naoka Kamio, Yasuo Miura, Masakazu Nakano, Daniel G Tenen, Shinya Kimura, Kei Tashiro, Taira Maekawa
Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib;　2019/02 ANNOUNCEMENT INFO.;　J Pharm Anal, 9, 1, 49-54 AUTHOR;　Rintaro Sogawa, Tetsuya Saita, Yuta Yamamoto, Sakiko Kimura, Yutaka Narisawa, Shinya Kimura, Masashi Shin
Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma;　2019/02 ANNOUNCEMENT INFO.;　Ann Hematol, 98, 2, 465-471 AUTHOR;　Hiroshi Ureshino, Kana Kusaba, Keisuke Kidoguchi, Haruhiko Sano, Atsujiro Nishioka, Hidekazu Itamura, Mariko Yoshimura, Masako Yokoo, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Eisaburo Sueoka, Shinya Kimura
Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method. ;　2018 ANNOUNCEMENT INFO.;　Int J Hematol. , 108, 4, 416-422 AUTHOR;　*Itamura H, Ide M, Sato A, Sueoka-Aragane N, Sueoka E, Nishida A, Masunari T, Aoki S, Takizawa J, Suzumiya J, Kimura S
Current Status and Problems of T790M Detection, a Molecular Biomarker of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, with Liquid Biopsy and Re-biopsy.;　2018 ANNOUNCEMENT INFO.;　Anticancer Res. , 38, 6, 3559-3566 AUTHOR;　Komiya K, Nakashima C, Nakamura T, Hirakawa H, Abe T, Ogusu S, Takahashi K, Takeda Y, Egashira Y, Kimura S, Sueoka-Aragane N
Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma. ;　2018 ANNOUNCEMENT INFO.;　Oncotarget. , 9, 47, 28547-28560 AUTHOR;　Maeda A, Nishida Y, Weetall M, Cao L, Branstrom A, Ishizawa J, Nii T, SchoberWD, Abe Y, Matsue K, Yoshimura M, Kimura S, Kojima K.
Mechanisms of acquired resistance to afatinib clarified with liquid biopsy;　2018 ANNOUNCEMENT INFO.;　PLoS One. , 13, 12, e0209384 AUTHOR;　Nakamura T, Nakashima C, Komiya K, Kitera K, Hirai M, Kimura S, Sueoka-Aragane N
Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments.;　2018 ANNOUNCEMENT INFO.;　Oncotarget. , 9, 38, 25181?25192 AUTHOR;　Nakashima C, Sato A, Abe T, Kato J, Hirai M, Nakamura T, Komiya K, Sueoka E, Kimura S, Sueoka-Aragane N.
Final 3-year results of the Dasatinib Discontinuation Trial in Patients with Chronic Myeloid Leukemia who received dasatinib as a second line treatment;　2018 ANNOUNCEMENT INFO.;　Clin Lymphoma Myeloma Leuk. , 18, 5, 353-360.e1 AUTHOR;　*Okada M, Imagawa J, Tanaka H, Nakamae H, Hino M, Murai K, Ishida Y, Kumagai T, Sato S, Ohashi K, Sakamaki H, Wakita H, Uoshima N, Nakagawa Y, Minami Y, Ogasawara M, Takeoka T, Akasaka H, Utsumi T, Uike N, Sato T Ando S, Usuki K, Mizuta S, Hashino S, Nomura T, Shikami M, Fukutani H, Ohe Y, Kosugi H, Shibayama H, Maeda Y, Fukushima T, Yamazaki H, Tsubaki K, Kukita T, Adachi Y, Nataduka T, Sakoda H, Yokoyama H, Okamoto T, Shirasugi Y, Onishi Y, Nohgawa M, Yoshihara S, Morita S, Sakamoto J, Kimura S; DADI Trial Group, Japan.
Prognostic impact of Acute myeloid leukemia with low allelic ratio FLT3-ITD and NPM1 mutation.;　2018 ANNOUNCEMENT INFO.;　Blood Adv. , 2, 20, 2744-2754 AUTHOR;　Sakaguchi M, Yamaguchi H, Najima Y, Usuki K, Ueki T, Oh I, Mori S, Kawata E, Uoshima N, Kobayashi Y, Kako S, Tajika K, Gomi S, Shono K, Kayamori K, Hagihara M, Kanda J, Uchiyama H, Kuroda J, Uchida N, Kubota Y, Kimura S, Kurosawa S, Nakajima N, Marumo A, Omori I, Fujiwara Y, Yui S, Wakita S, Arai K, Kitano T, Kakihana K, Kanda Y, Ohashi K, Fukuda T, Inokuchi K
Anxiety and depression associated with tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia;　2018 ANNOUNCEMENT INFO.;　Int J Clin Oncol. , 23, 5, 974-979 AUTHOR;　Sogawa R, Kimura S, Yakabe R, Mizokami Y, Tasaki M, Sueoka-Aragane N, Narisawa Y, Kimura S.
Investigation of Appropriate Pre-analytical Procedure for Circulating Free DNA from Liquid Biopsy.;　2018 ANNOUNCEMENT INFO.;　Oncotarget. , 9, 61, 31904-31914 AUTHOR;　○Sato A, Nakashima C, Abe T, Kato J, Hiai M, Nakamura T, Komiya K, Kimura S, Sueoka E, Sueoka-Aragane N.
Relationship between the duration of trimethoprim/sulfamethoxazole treatment and the clinical outcome of pulmonary nocardiosis.;　2018 ANNOUNCEMENT INFO.;　Respir Investig. , 56, 2, 166-172 AUTHOR;　*Tashiro H, Takahashi K, Kusaba K, Tanaka M, Komiya K, Nakamura T, Aoki Y, Kimura S, Sueoka-Aragane N
Allelic polymorphisms of KIRs and HLAs predict favorable responses to tyrosine kinase inhibitors in CML.;　2018 ANNOUNCEMENT INFO.;　Cancer Immunol Res. , 6, 6, 745-754 AUTHOR;　Ureshino H, Shindo T, Kojma H, Kusunoki Y, Miyazaki Y, Tanaka H, Saji H, Kawaguchi A, Kimura S
Efficacy of reduced-dose dasatinib as a subsequent therapy in patients with chronic myeloid leukemia in the chronic phase: The LD-CML study of the Kanto CML Study Group.;　2018 ANNOUNCEMENT INFO.;　Intern Med. , 57, 1, 17-23 AUTHOR;　Iriyama N, Ohashi K, Hashino S, Kimura S, Nakaseko C, Takano H, Uchiyama M, Morita S, Sakamoto J, Sakamaki H, Inokuchi K
Chemotherapy for primary mediastinal yolk sac tumor in a patient undergoing chronic hemodialysis: a case report.;　2017 ANNOUNCEMENT INFO.;　J Med Case Rep. , 11, 1, 43 AUTHOR;　Hirakawa H, Nakashima C, Nakamura T, Masuda M, Funakoshi T, Nakagawa S, Horimatsu T, Matsubara K, Muto M, Kimura S, Sueoka-Aragane N
Elderly patients with chronic myeloid leukemia benefit from a dasatinib dose as low as 20 mg.;　2017 ANNOUNCEMENT INFO.;　Clin Lymphoma Myeloma Leuk. , 17, 6, 370-374 AUTHOR;　Itamura H, Kubota Y, Shindo T, Ando T, Kojima K, Kimura S
Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer.;　2017 ANNOUNCEMENT INFO.;　Lung Cancer. , 110, 35-41 AUTHOR;　Kobayashi-Watanabe N, Sato A, Watanabe T, Abe T, Nakashima C, Sueoka E, Kimura S, Sueoka-Aragane N.
Peculiar cold-induced leukoagglutination in Mycoplasma pneumoniae pneumonia.;　2017 ANNOUNCEMENT INFO.;　Turk J Haematol. , 34, 4, 354-355 AUTHOR;　Kubota Y, Hirakawa Y, Wakayama K, Kimura S
Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer.;　2017 ANNOUNCEMENT INFO.;　Med Oncol. , 34, 12, 195 AUTHOR;　＊Miyahara T, Sueoka-Aragane N, Iwanaga K, Ureshino N, Komiya K, Nakamura T, Nakashima C, Abe T, Matsunaga H, Kimura S.
Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge.;　2017 ANNOUNCEMENT INFO.;　Oncol Lett. , 13, 6, 4939-4946 AUTHOR;　Nakamura T, Watanabe N, Sato A, Komiya K, Umeguchi H, Hosomi T, Hirai M, Sueoka E, Kimura S, Sueoka-Aragane N
Automatic digital quantification of bone marrow myeloma volume in appendicular skeletons - clinical implications and prognostic significance.;　2017 ANNOUNCEMENT INFO.;　Sci Rep. , 7, 1, 12885 AUTHOR;　Nishida Y, Kimura S, Mizobe H, Yamamichi J, Kojima K, Kawaguchi A, Fujisawa M, Matsue K
Deep sequencing of the T cell receptor visualizes reconstitution of T cell immunity in mogamulizumab-treated adult T cell leukemia ;　2017 ANNOUNCEMENT INFO.;　Oncoimmunology. , 7, 3, e1405204 AUTHOR;　Takero Shindo, Kazutaka Kitaura, Hiroshi Ureshino, Kazuharu Kamachi, Masaharu Miyahara, Kazuko Doi, Tatsuro Watanabe, Eisaburo Sueoka, Tadasu Shin-I, Ryuji Suzuki and Shinya Kimura
Thin-section CT findings of multicentric Castleman disease changing over 10 years.;　2017 ANNOUNCEMENT INFO.;　J Thorac Imaging. , 32, 6, W81-W83 AUTHOR;　Tashiro H, Egashira R, Takahashi K, Fukui S, Kimura S, Nakazono T, Nojiri J, Fukuoka J, Irie H, Sueoka-Aragane N.
Pre-existing chronic interstitial pneumonia is poor prognostic factor of Goodpasture's syndrome: a case and review of the literature;　2017 ANNOUNCEMENT INFO.;　J Med Case Rep. , 11, 1, 102 AUTHOR;　Tashiro H, Takahashi K, Ikeda Y, Uchiumi S, Fukuda M, Miyazono M, Kimura S, Sueoka-Aragane N.
Saturated Fatty Acid Increases Lung Macrophages and Augments House Dust Mite-Induced Airway Inflammation in Mice Fed with High-Fat Diet.;　2017 ANNOUNCEMENT INFO.;　Inflammation. , 40, 3, 1072-1086 AUTHOR;　Tashiro H, Takahashi K, Sadamatsu H, Kato G, Kurata K, Kimura S, Sueoka-Aragane N.
Characteristics and prognosis of microscopic polyangiitis with bronchiectasis, Journal of Thoracic Disease;　2017 ANNOUNCEMENT INFO.;　J Thorac Dis., 9, 2, 303-309 AUTHOR;　Tashiro H, Takahashi K, Tanaka M, Komiya K, Nakamura T, Kimura S, Tada Y, Sueoka-Aragane N
The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells;　2017 ANNOUNCEMENT INFO.;　Blood Cancer J., 7, 2, e527 AUTHOR;　Y Nishida, A Maeda, MJ Kim, L Cao, Y Kubota, J Ishizawa, A AlRawi, Y Kato, A Iwama, M Fujisawa, K Matsue, M Weetall, M Dumble, M Andreeff, TW Davis, A Branstrom, S Kimura, K Kojima
Mutation profile of B-raf gene analyzed by fully automated system and clinical features in Japanese melanoma patients;　2017 ANNOUNCEMENT INFO.;　Pathol Oncol Res., 23, 1, 181-188 AUTHOR;　Ide M, Koba K, Sueoka-Aragane N, Sato A, Nagano Y, Inoue T, Misago N, Narisawa Y, Kimura S, Sueoka E
Detection of KRAS Mutations in plasma DNA using a fully automated rapid detection system in colorectal cancer patients;　2017 ANNOUNCEMENT INFO.;　Pathol Oncol Res., 23, 4, 737-744 AUTHOR;　Hosoya K, Matsusaka S, Kashiwada T, Suzuki K, Ureshino N, Sato A, Miki Y, Kitera K, Hirai M, Hatake K, Kimura S, Sueoka-Aragane N
Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia.;　2016 ANNOUNCEMENT INFO.;　Cancer Immunol Res., 4, 8, 644-9 AUTHOR;　Ureshino H, Shindo T, Nishikawa H, Watanabe N, Watanabe E, Satoh N, Kitaura K, Kitamura H, Doi K, Nagase K, Kimura H, Sakurai R, Baba R, Kurogi K, Samukawa M, Kusunoki S, Miyahara M, Suzuki R, Sakaguchi S, Kimura S.
Interleukin-33 from monocytes recruited to the lung contributes to house dust mite-induced airway inflammation in a mouse model.;　2016 ANNOUNCEMENT INFO.;　PLoS One., 11, 6, e0157571 AUTHOR;　Tashiro H, Takahashi K, Hayashi S, Kato G, Kurata K, Kimura S, Sueoka-Aragane N.
Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study.;　2016 ANNOUNCEMENT INFO.;　Cancer Sci., 107, 2, 162-7 AUTHOR;　Sueoka-Aragane N, Katakami N, Miyako M, Yokota S, Aoe K, Iwanaga K, Otsuka K, Morita S, Kimura S, Negoro S.
Clinical features of Japanese polycythemia vera and essential thrombocythemia patients harboring CALR, JAK2V617F, JAK2Ex12del, and MPLW515L/K mutations.;　2016 ANNOUNCEMENT INFO.;　Leuk Res., 40, 68-76 AUTHOR;　＊Okabe M, Yamaguchi H, Usuki K, Kobayashi Y, Kawada E, Kuroda J, Kimura S, Tajika K, Gomi S, Arima N, Mori S, Ishida Y, Koizumi M, Ito Y, Wakita S, Araua K, Kitano T, Kosaka F, Dan K, Inokuchi K.
Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome-Positive Lymphoid Leukemia.;　2016 ANNOUNCEMENT INFO.;　Mol Cancer Ther., 15, 1, 94-105 AUTHOR;　＊Nemoto A, Saida D, Kato I, Kikuchi J, Furukawa Y, Maeda Y, Akahane K, Honna-Oshiro H, Goi K, Kagami K, Kimura S, SatoY, Okabe S, Niwa A, Watanabe K, Nakahata T, Heike T, Sugita K. Inukai T.
Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy.;　2016 ANNOUNCEMENT INFO.;　Leuk Res., 51, 11-18 AUTHOR;　＊Miyamura K, Miyamoto T, Tanimoto M, Yamamoto K, Kimura S, Kawaguchi T, Matsumura I, Hata T, Tsurumi H, Saito S, Hino M, Tadokoro S, Meguro K, Hyodo H, Yamamoto M, Kubo K, Tsukada J, Kondo M, Aoki M, Okada H, Yanada M, Ohyashiki K, Taniwaki M.
The combination of panobinostat with ponatinib synergistically overcomes imatinib-resistant CML cells.;　2016 ANNOUNCEMENT INFO.;　Cancer Sci., 107, 7, 1029-38 AUTHOR;　＊Matsuda Y, Yamauchi T, Hosono N, Uzui K, Negoro E, Morinaga K, Nishi R, Yoshida A, Kimura S, Maekawa T. Ueda T.
Rapid sensitive analysis of IDH-1 mutation in low-grade gliomas by automated genetic typing involving a quenching probe.;　2016 ANNOUNCEMENT INFO.;　Cancer Invest., 34, 1, 12-5 AUTHOR;　＊Kurimoto M, Suzuki H, Aoki K, Ohka F, Kondo G, Motomura K, Iijima K, Yamamichi A, Ranjit M, Wakabayashi T, Kimura S, Natsume A.
SPARC is a Possible Predictive Marker for Albumin-bound Paclitaxel in Non-small Cell Lung Cancer.;　2016 ANNOUNCEMENT INFO.;　Onco Targets Ther., 9, 6663-6668 AUTHOR;　Komiya K, Nakamura T, Sadamatsu H, Nakashima C, Takahashi K, Umeguchi H, Watanabe N, Sato A, Takeda Y, Kimura S, Sueoka-Aragane N
The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma.;　2016 ANNOUNCEMENT INFO.;　Oncotarget., 7, 43, 69625-69637 AUTHOR;　Kojima K, Maeda A, Yohimura M, Nishida Y, Kimura S
The MEK Inhibitor Trametinib Separates Murine Graft-versus-Host Disease from Graft-versus-Tumor Effects.;　2016 ANNOUNCEMENT INFO.;　JCI Insight., 1, 10, e86331 AUTHOR;　Itamura H, Shindo T, Tawara I, Kubota Y, Kariya R, Okada S, Komanduri KV, Kimura S.
Torin2 potentiates anti-cancer effects for adult T-cell leukemia/lymphoma by inhibiting mammalian target of rapamycin.;　2016 ANNOUNCEMENT INFO.;　Anticancer Res., https://www.ncbi.nlm.nih.gov/labs/articles/26722032/, 36, 1, 95-102 AUTHOR;　 Watanabe T, Sato A, Kobayashi-Watanabe N, Sueoka-Aragane N, Kimura S, Sueoka E
For Hanshin-Saga Collaborative Cancer Study Group. Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study.;　2016 ANNOUNCEMENT INFO.;　Cancer Sci., 107, 2, 162-7 AUTHOR;　Sueoka-Aragane N, Katakami N, Satouchi M, Yokota S, Aoe K, Iwanaga K, Otsuka K, Morita S, Kimura S, Negoro S
2-Hydroxypropyl-β-cyclodextrin Acts as a Novel Anticancer Agent.;　2015 ANNOUNCEMENT INFO.;　PLoS One., 10, 11, e0141946 AUTHOR;　Yokoo M, Kubota Y, Motoyama K, Higashi T, Taniyoshi M, Tokumaru H, Nishiyama R, Tabe Y, Mochinaga S, Sato A, Sueoka-Aragane N, Sueoka E, Arima H, Irie T, Kimura S
Evaluation of a cloud-based local-read paradigm for imaging evaluations in oncology clinical trials for lung cancer.;　2015 ANNOUNCEMENT INFO.;　Acta Radiol Open., 4, 12, 2058460115588103 AUTHOR;　Sueoka-Aragane N, Kobayashi N, Bonnard E, Charbonnier C, Yamamichi J, Mizobe H, Kimura S
Isopentenyl pyrophosphate secreted from Zoledronate-stimulated myeloma cells, activates the chemotaxis of γδT cells.;　2015 ANNOUNCEMENT INFO.;　Biochem Biophys Res Commun., 463, 4, 650-5 AUTHOR;　Ahihara E, Munaka T, Kimura S, Nakagawa S, Naakagawa Y, Kanai M, Hirai H, Abe H, Miida T, Yamato S, Shoji S, Maekawa T.
Failure mode and effects analysis of medication adherence in patients with chronic myeloid leukemia.;　2015 ANNOUNCEMENT INFO.;　Int J Clin Oncol., 20, 6, 1203-10 AUTHOR;　Hosoya K, Mochinaga S, Emoto A, Yokoo H, Tokushima H, Egoshi M, Sueoka-Aragane N, Kimura S
Discontinuation of dasatinib in chronic myeloid leukaemia patients who have maintained deep molecular response for more than 1 year: the prospective, multicentre Dasatinib Discontinuation (DADI) Trial.;　2015 ANNOUNCEMENT INFO.;　Lancet Haematol., 2, 12, e528-35 AUTHOR;　Imagawa J, Tanaka H, Okada M, Nakamae H, Hino M, Murai K, Ishida Y, Kumagai T, Sato S, Ohashi K, Sakamaki H, Wakita H, Uoshima N, Nakagawa Y, Minami Y, Ogasawara M, Takeoka T, Akasaka H, Utsumi T, Uike N, Sato T, Ando S, Usuki K, Morita S, Sakamoto J, Kimura S
Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity;　2015 ANNOUNCEMENT INFO.;　Biochem Biophys Res Commun., 457, 3, 288-94 AUTHOR;　Matsuda K, Hattori S, Kariya R, Komizu Y, Kudo E, Goto H, Taura M, Ueoka R, Kimura S, Okada S.
Preclinical activity of the novel BMI-1 inhibitor PTC-209 in acute myeloid leukemia: implications for leukemia therapy.;　2015 ANNOUNCEMENT INFO.;　Cancer Sci., 106, 12, 1705-13 AUTHOR;　Nishida Y, Maeda A, Chachad D, Ishizawa J, Yi Hua Q, Kornblau SM, Kimura S, Andreeff M, Kojima K
Volume-based response evaluations with consensual lesion selection using cloud solutions (SaaS) in clinical trials: a pilot study;　2015 ANNOUNCEMENT INFO.;　Acad Radiol., 22, 2, 217-25 AUTHOR;　Oubel E, Bonnard E, Sueoka-Aragane N, Kobayashi N, Charbonnier C, Yamamichi J, Mizobe H, Kimura S
Usefulness of plasma HGF level for monitoring acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer;　2015 ANNOUNCEMENT INFO.;　Oncol Rep., 33, 1, 391-6 AUTHOR;　Umeguchi H, Sueoka-Aragane N, Kobayashi N, Nakamura T, Sato A, Takeda Y, Hayashi S, Sueoka E, Kimura S.
Comparative study of the anti-leukemic effects of imatinib mesylate, GlivecTM tablet and its generic formulation, OHK9511;　2015 ANNOUNCEMENT INFO.;　Biol Pharm Bull., 38, 3, 411-6 AUTHOR;　Yokoo M, Kubota Y, Tabe Y, Kimura S
A novel frameshift mutation in exon 4 causes deficiency of high molecular weight kininogen;　2014 ANNOUNCEMENT INFO.;　Intern Med. , 53, 3, 253-7 AUTHOR;　Fukushima N, Itamura H, Wada H, Ikejiri M, Igarashi Y, Sano M, Komiyama Y, Icinohe T, Kimura S
Small lymphocytic lymphoma presenting as bulky renal incidentaloma.;　2014 ANNOUNCEMENT INFO.;　Int J Hematol. , 100, 2, 107-8 AUTHOR;　Kamachi K, Kojima K, Nishijima A, Takeshita M, Ando T, Kimura S
2 Adrenergic Agonist Attenuates HDM-induced Allergic Airway Inflammation through Dendritic Cells.;　2014 ANNOUNCEMENT INFO.;　BMC Immunol. , 15, 1, 39 AUTHOR;　Kato G, Tahakashi K, Kurata K, Shirai H, Kimura S, Hayashi S.
Diffuse bone marrow uptake of fluorodeoxyglucose in a patient with aleukaemic acute lymphoblastic leukaemia.;　2014 ANNOUNCEMENT INFO.;　Br J Haematol. , 166, 1, 2 AUTHOR;　Kitamura H, Ando T, Kojima K, Komiya K, Sueoka-Aragane N, Kimura S.
Bilateral renal infiltration as the initial presentation of multiple myeloma.;　2014 ANNOUNCEMENT INFO.;　Br J Haematol. , 167, 1, 2 AUTHOR;　Kubota Y, Matsuzaki M, Kimura S
Combining the ABL1 kinase inhibitor ponatinib and the histone deacetylase inhibitor vorinostat: A potential treatment for BCR-ABL positive leukemia;　2014 ANNOUNCEMENT INFO.;　PLoS One. , 9, 2, e89080 AUTHOR;　Okabe S, Tauchi T, Kimura S, Maekawa T, Ohyashiki K,
Ohyashiki K. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with nilotinib against BCR-ABL–positive leukemia cells involves the ABL kinase domain mutation.;　2014 ANNOUNCEMENT INFO.;　Cancer Biol Ther. , 15, 2, 207-15 AUTHOR;　Okabe S, Tauchi T, Tanaka Y, Kimura S, Maekawa T
Mogamulizumab treatment in a hemodialysis patient with adult T-cell leukemia/lymphoma.;　2014 ANNOUNCEMENT INFO.;　Turk J Haematol. , 31, 4, 424-425 AUTHOR;　Yoshihara M, Kubota Y, Fukuda M, Kishi T, Ikeda Y, Kimura S.
Induction of p53 transcription and apoptosis by Exportin-1 (XPO1) inhibition in mantle cell lymphoma.;　2014 ANNOUNCEMENT INFO.;　Cancer Sci. , 105, 7, 795-801 AUTHOR;　Yoshimura M, Ishizawa J, Dilip A, Ruvolo V, Quintas-Cardama A, McDonnel TJ, Neelapu SS, Kwak LW, Shachem S, Kauffman M, Yokoo M, Kimura S, Andreeff M, Kojima K.
ABL tyrosine kinase inhibitor–induced pulmonary alveolar proteinosis in chronic myeloid leukemia.;　2014 ANNOUNCEMENT INFO.;　Int J Hematol. , 100, 6, 611-4 AUTHOR;　Yoshimura M, Kojima K, Tomimasu R, Fukushima N, Hayashi S, Sueoka E, Kimura S.
Correlation between plasma DNA and tumor status in an animal model. ;　2014 ANNOUNCEMENT INFO.;　PLoS One., 9, 12, e111881 AUTHOR;　Sueoka-Aragane N, Sato A, Kobayashi N, Ide M, Yokoo M, Nagano Y, Sueoka E, Kimura S
Therapeutic management in cardiac lymphoma.;　2014 ANNOUNCEMENT INFO.;　Leuk Lymphoma., 55, 5, 1215-1217 AUTHOR;　Yoshihara M, Itamura H, Fukushima N, Itoh M, Furukawa K, Nagatomo D, Kamachi K, Kitamura H, Shindo T, Kubota Y, Sueoka E, Morita S, Ichinohe T, Kimura S
Neuroprotective efficacy of a new brain-penetrating c-Abl inhibitor in a murine Parkinson's disease model.;　2013 ANNOUNCEMENT INFO.;　PLoS One, doi: 10.1371/journal.pone.0065129, 8, 5, e65129 AUTHOR;　Imam SZ, Trickler W, Kimura S, Binienda ZK, Paule MG, Slikker W, Li S, Clark RA, Ali SF.
Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells.;　2013 ANNOUNCEMENT INFO.;　Cancer Cell Int, 13, 1, 32 AUTHOR;　Okabe S, Tauchi T, Tanaka Y, Kimura S, Maekawa T, Ohyashiki K.
Development of lymphoproliferative diseases by hypoxia inducible factor-1a is associated with prolonged lymphocyte survival.;　2013 ANNOUNCEMENT INFO.;　PLOS One, 8, 4, e57833 AUTHOR;　Sueoka E, Sueoka-Aragane N, Sato A, Ide M, Nakamura H, Sotomaru Y, Taya C, Yonekawa H, Kitagawa T, Kubota Y, Kimura S, Nakamichi K, Tanimoto K.
Development of lymphoproliferative diseases by hypoxia inducible factor-1alpha is associated with prolonged lymphocyte survival.;　2013 ANNOUNCEMENT INFO.;　PLoS One., 8, 4, e57833 AUTHOR;　○Sueoka E, Sueoka-Aragane N, Sato A, Ide M, Nakamura H, Sotomaru Y, Taya C, Yonekawa H, Kitagawa T, Kubota Y, Kimura S, Nakachi K, Tanimoto K.
Severe eosinophilic pneumonia presenting during gemcitabine adjuvant chemotherapy.;　2013 ANNOUNCEMENT INFO.;　World J Surg Oncol, 11, 167 AUTHOR;　Yakabe T, Kitahara K, Komiya K, Sueoka-Aragane N, Kimura S, Sugioka T, Noshiro H.
Targeting the hedgehog signaling pathway in therapy-resistant BCR-ABL1 positive leukemia with ponatinib.;　2013 ANNOUNCEMENT INFO.;　Clin Cancer Res, 19, 6, 1422-1432 AUTHOR;　Katagiri S, Tauchi T, Okabe S, Minami Y, Kimura S, Maekawa T, Naoe T, Ohyashiki K.
Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study.;　2013 ANNOUNCEMENT INFO.;　Biomark Insights. doi: 10.4137/BMI.S12537, 8, 97-105 AUTHOR;　Kato G, Takahashi K, Izuhara K, Komiya K, Kimura S and Hayashi S.
Ever-advancing chronic myeloid leukemia treatment;　2013 ANNOUNCEMENT INFO.;　Int J Clin Oncol., 19, 1, 3-9 AUTHOR;　Kimura S, Ando T, Kojima K
Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells.;　2013 ANNOUNCEMENT INFO.;　Bioorgan Med Chem Lett, 23, 3, 606-609 AUTHOR;　Kudo E, Taura M, Matsuda K, Shimamoto M, Kariya R, Goto H, Hattori S, Kimura S, Okada S.
Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients.;　2013 ANNOUNCEMENT INFO.;　Cancer Chemother Pharmacol., 71, 1, 175-182 AUTHOR;　○Miyahara T, Mochinaga S, Kimura S, Aragane N, Yakabe T, Morita S, Okudaira K, Fujito H.
β-2 microglobulin is unsuitable as an internal reference for the analysis of gene expression in human colorectal cancer;　2013 ANNOUNCEMENT INFO.;　Biomed Rep, 1, 2, 193-196 AUTHOR;　Nihon-Yanagi Y, Terai K, Murano T, Kawai T, Kimura S, Okazumi S
An automated rapid detection system using the quenching probe method for detecting interleukin 28B and inosine triphosphatase single nucleotide polymorphisms in chronic hepatitis C.;　2013 ANNOUNCEMENT INFO.;　J Viral Hepat, 20, 4, e124-e126 AUTHOR;　Takahashi H, Mizuta T, Oeda S, Isoda H, Nakashita S, Kawaguchi Y, Izumi N, Hirai M, Kurose K, Iwane S, Eguchi Y, Kimura S, Anzai K, Ozaki I
Uncommon case of chronic myeloid leukemia with multiple myeloma.;　2010 ANNOUNCEMENT INFO.;　Int J Hemmatol,, 91, 4, 699-704 AUTHOR;　Ide M, Kuwahara N, Matsuishi E, Kimura S, Gondo H.
Phase I study of INNO-406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome-positive leukemias post-imatinib resistance or intolerance.;　2010 ANNOUNCEMENT INFO.;　Cancer, 116, 11, 2665-2672 AUTHOR;　*Kantarjian H, le Coutre P, Cortes J, Pinilla-lbarz J, Nagler A, Hochhaus A, Kimura S, Ottmann O
Targeting ATF-3 by Galectin-9 induces apoptosis and overcomes various types of treatment resistance in chronic myelogenous leukemia.;　2010 ANNOUNCEMENT INFO.;　Mol Cancer Res,, 8, 7, 994-1001 AUTHOR;　Kuroda J, Kobayashi T, Nagoshi H, Yamamoto M, Sasaki N, Taki T, Kimura S, Yamauchi A, Hirashima M, Taniwaki M
Glyoxalase-I is a novel target against Bcr-Abl+ leukemic cells acquiring stem-like characteristics in hypoxic environment.;　2010 ANNOUNCEMENT INFO.;　Cell Death Diff, 17, 7, 1211-1220 AUTHOR;　*Takeuchi M, Kimura S, Kuroda J, Ashihara E, Kawatani M, Osada H, Umezawa K, Yasui E, Imoto M, Tsuruo T, Yokota A, Tanaka R, Nagao R, Nakahara T, Fujiyama Y, Maekawa T
Gangrenous cheilitis associated with all-trans retinoic acid therapy for acute promyelocytic leukemia.;　2010 ANNOUNCEMENT INFO.;　Int J Hematol,, 91, 1, 132-135 AUTHOR;　Tanaka M, Fukushima N, Urata C, Yokoo M, Ide M, HIsatomi T, Tomimasu R, Sueoka E
Primary hepatic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue type is associated with chronic inflammatory process;　2010 ANNOUNCEMENT INFO.;　Open J Hematol, 1-5 AUTHOR;　Tanaka M, Fukushima N, Yamasaki F, Ohshima K, Sueoka E, Kimura S
Activity of the multi-targeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL positive leukemic cells.;　2010 ANNOUNCEMENT INFO.;　Blood, 116, 2089-2095 AUTHOR;　*Tanaka R, Squires MS, Kimura S, Yokota A, Nagao R, Yamauchi T, Takeuchi M, Yao H, Reule M, Smyth T, Lyon JF, Thompson NT, Ashihara E, Ottmann OG, Maekawa T
A Fully Integrated and Automated Detection System for Single Nucleotide Polymorphisms of UGT1A1 and CYP2C19.;　2010 ANNOUNCEMENT INFO.;　Oncol Res AUTHOR;　Ureshino N, Aragane N, Nakamura T, Ide M, Mochinaga S, Fukushima N, Hayashi S, Sueoka E, Kimura S
Osteoclasts are involved in the maintenance of dormant leukemic cells.;　2010 ANNOUNCEMENT INFO.;　Leuk Res., 34, 793-799 AUTHOR;　Yokota A, Kimura S, Tanaka R, Takeuchi M, Yao H, Sakai K, Nagao R, Kuroda J, Kamitsuji Y, Kawata E, Ashihara E, Maekawa T
Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier.;　2009 ANNOUNCEMENT INFO.;　Ann Oncol. AUTHOR;　Fukushima N, Mizuta T, Tanaka M, Yokoo M, Ide M, Hisatomi T, Kuwahara N, Tomimasu R, Tsuneyoshi N, Funai N, Sueoka E
Intravesical administration of gd T cells successfully prevents the growth of bladder cancer in the murine model.;　2009 ANNOUNCEMENT INFO.;　Cancer Immunol Immun, 58, 493-502 AUTHOR;　* Yuasa T, Sato K, Ashihara E, Takeuchi M, Maita S, Tsuchiya N, Habuchi T, Maekawa T, Kimura S*.

Material, Commentary, Editorials, Research Report, A Comprehensive Journal Articles

A patient with antibody against low-frequency red blood cell antigen Co^b;　2020/07 ANNOUNCEMENT INFO.;　Japanese Journal of Medical Technology, 69, 3, 445 - 450 AUTHOR;　○Mami NAKAO, Marie YAMADA, Naotomo YAMADA, Seiji KAWASAKI, Hideaki NAKAMURA, Yasushi KUBOTA, Shinya KIMURA, Eizaburo SUEOKA
Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation.;　2020/02 ANNOUNCEMENT INFO.;　Ann Hematol. , 99, 2, 389-390 AUTHOR;　Yamaguchi K, Kubota Y, Kishimori C, Ohno H, Kidoguchi K, Kizuka-Sano H, Nishioka A, Katsuya H, Ando T, Kimura S.
A Case of Superficial-Type Gastric Cancer with Metastatic Ovarian Cancer Diagnosed by Exploratory Laparotomy;　2020/01 ANNOUNCEMENT INFO.;　Gan To Kagaku Ryoho, 47, 1, 159-161 AUTHOR;　
Mesalazine-induced airway obstruction: Utility of pulmonary function testing in drug-induced lung diseases.;　2019/11 ANNOUNCEMENT INFO.;　Respir Investig. , 57, 6, 611-614 AUTHOR;　Hirakawa H, Tashiro H, Takahashi K, Tanaka M, Sadamatsu H, Kimura S, Sueoka-Aragane N.
Severe infusion reaction, anti-rituximab antibodies and lymphoma.;　2019/11 ANNOUNCEMENT INFO.;　QJM. AUTHOR;　Kidoguchi K, Kubota Y, Kusaba K, Kizuka-Sano H, Yamaguchi K, Nishioka A, Yokoo M, Ando T, Kojima K, Kimura S.
BCR-ABL1- and CBFB-MYH11- positive chronic myeloid leukemiapresenting with primary blast crisis and marrow fibrosis;　2019/10 ANNOUNCEMENT INFO.;　Ann Hematol. , 98, 10, 2461-2462 AUTHOR;　Kidoguchi K, Kojima K, Yokoo M, Kimura S.
Primary Chest Wall MYC/BCL6 Double-hit Lymphoma with t (3;7) (q27;p12) and t (8;14) (q24;q32) Translocations.;　2019/07 ANNOUNCEMENT INFO.;　Intern Med. , 58, 14, 2073-2077 AUTHOR;　Kamachi K, Kubota Y, Nagaie T, Yamaguchi K, Ogusu S, Kidoguchi K, Kusaba K, Kizuka-Sano H, Nishioka A, Yoshimura M, Yokoo M, Ando T, Kai K, Kojima K, Ohshima K, Sueoka E, Kimura S.
Is clinicopathological distinction of mucosa-associated lymphoid tissue lymphoma from Waldenstrom macroglobulinemia essential in MYD88 L265P mutation-positive cases?;　2019/03 ANNOUNCEMENT INFO.;　Int J Hematol. , 109, 3, 247-248 AUTHOR;　Kidoguchi K, Kojima K, Seki R, Nagafuji K, Oshima K, Kimura S.
Epstein-Barr virus-related diffuse large B-cell lymphoma in mogamulizumab-treated adult T-cell leukemia with incomplete T-cell reconstitution.;　2019/02 ANNOUNCEMENT INFO.;　Int J Hematol. , 109, 2, 221-227 AUTHOR;　Kamachi K, Shindo T, Miyahara M, Kitaura K, Akashi M, Shin-I T, Suzuki R, Oshima K, Kimura S
Acute myeloid leukemia with t(19;21)(q13;q22) transformed from myelodysplastic syndrome with marked eosinophilia.;　2019 ANNOUNCEMENT INFO.;　Ann Haematol, 98, 1, 221-222 AUTHOR;　Kubota Y, Kamachi K, Wakayama K, Kitamura H, Yoshihara M, Hisatomi T, Fukushima N, Ichinohe T, Sueoka E, Kimura S
Successful treatment of post-transplant relapsed adult T cell leukemia after cord blood transplantation with low-dose, short-term lenalidomide.;　2018 ANNOUNCEMENT INFO.;　Leuk Lymphoma. , 59, 10, 2474-2477 AUTHOR;　Ando T, Kojima K, Sano H, Kidoguchi K, Kusaba K, Yoshimura M, Yokoo M, Kubota Y, Nakamura H, Takase Y, Aishima S, Kimura S
A case of osimertinib-resistant lung adenocarcinoma responded effectively to alternating therapy.;　2018 ANNOUNCEMENT INFO.;　Ann Transl Med. , 6, 23, 464 AUTHOR;　Hirakawa H, Komiya K, Nakashima C, Ogusu S, Nakamura T, Tanaka M, Takahashi K, Egashira Y, Kai K, Kimura S. Sueoka-Aragane N
Synchronous mantle cell lymphoma and lung adenocarcinoma presenting in a pleural effusion: a rare tumor combination and a potential pitfall of cytodiagnosis;　2018 ANNOUNCEMENT INFO.;　Cytopathology, 29, 4, 400-402 AUTHOR;　○Kai K, Ryu Y, Kamachi K, Nishioka A, Kubota Y, Nakamura M, Kimura S, Sueoka E, Aishima S
Successful autologous hematopoietic stem cell transplantation followed by bortezomib maintenance in a patient with relapsed CD138-low multiple solitary plasmacytomas harboring 17p deletion.;　2018 ANNOUNCEMENT INFO.;　Intern Med. , 57, 6, 855-860 AUTHOR;　Kitamura H, Kubota Y, Yamaguchi K, Kamachi K, Nishioka A, Yokoo M, ShindoT, AndoT, Kojima K, Kimura S
Primary effusion lymphoma-like lymphoma with a T cell phenotype;　2018 ANNOUNCEMENT INFO.;　Ann Hematol, 97, 4, 717?718 AUTHOR;　*Kobayashi T, Mori D, Ureshino H, Kido S, Ikeda S, Kimura S, Lefpr AK, Matsuishi E
Three coexisting lymphomas in a single patient: Composite lymphoma derived from a common germinal center B-cell precursor and unrelated discordant lymphoma.;　2018 ANNOUNCEMENT INFO.;　Int J Hematol. , 107, 6, 703-708 AUTHOR;　Nishioka A, Ureshino H, Ando T, Kizuka H, Kusaba K, Sano H, Itamura H, Kubota Y, Kojima K, Ohshima K, Kimura S
Primary Pulmonary Colloid Adenocarcinoma: How Can We Obtain a Precise Diagnosis?;　2018 ANNOUNCEMENT INFO.;　Intern Med. , 57, 24, 3637-3641 AUTHOR;　Ogusu S, Takahashi K, Hirakawa H, Tanaka M, Komiya K, Nakamura T, Egashira R, Kai K, Takeda Y, Kimura S, Sueoka-Aragane N
Sj?gren Syndrome Complicated with Cystic Lung Disease and Pulmonary Amyloidosis. ;　2018 ANNOUNCEMENT INFO.;　Case Rep Rheumatol. , 2018, 7475242 AUTHOR;　Takahashi K, Sadamatsu H, Ogusu S, Komiya K, Nakamura T, Kimura S, Sueoka-Aragane N
Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma.;　2018 ANNOUNCEMENT INFO.;　Hematol Oncol. , 36, 1, 324-327 AUTHOR;　Ureshino H, Ando T, Kizuka H, Kusaba K, Sano H, Nishioka A, Itamura H, Shindo T, Kubota Y, Kojima K, Kimura S
Persistent Gastrointestinal Angiodysplasia in Heyde's Syndrome after Aortic Valve Replacement;　2017 ANNOUNCEMENT INFO.;　Intern Med. , 56, 18, 2431-2433 AUTHOR;　Akutagawa T, Shindo T, Yamanouchi K, Hayakawa M, Ureshino H, Tsuruoka N, Sakata Y, Shimoda R, Noguchi R, Furukawa K, Morita S, Iwakiri R, Kimura S, Matsumoto M, Fujimoto K.
Successful Autologous Hematopoietic Stem Cell Transplantation Followed by Bortezomib Maintenance in a Patient with Relapsed CD138-low Multiple Solitary Plasmacytomas Harboring a 17p Deletion.;　2017 ANNOUNCEMENT INFO.;　Intern Med. AUTHOR;　Kitamura H, Kubota Y, Yamaguchi K, Kamachi K, Nishioka A, Yokoo M, Shindo T, Ando T, Kojima K, Kimura S.
Primary effusion lymphoma-like lymphoma with a T cell phenotype;　2017 ANNOUNCEMENT INFO.;　Ann Hematol. AUTHOR;　Kobayashi T, Mori D, Ureshino H, Kido S, Ikeda S, Kimura S, Lefor AK, Matsuishi E.
Three coexisting lymphomas in a single patient: composite lymphoma derived from a common germinal center B-cell precursor and unrelated discordant lymphoma;　2017 ANNOUNCEMENT INFO.;　Int J Hematol. AUTHOR;　Nishioka A, Ureshino H, Ando T, Kizuka H, Kusaba K, Sano H, Itamura H, Kubota Y, Kojima K, Ohshima K, Kimura S.
Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma;　2017 ANNOUNCEMENT INFO.;　Hematol Oncol. AUTHOR;　Ureshino H, Ando T, Kizuka H, Kusaba K, Sano H, Nishioka A, Itamura H, Shindo T, Kubota Y, Kojima K, Kimura S.
5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10);　2017 ANNOUNCEMENT INFO.;　Int J Hematol., 105, 5, 692-696 AUTHOR;　Ureshino H, Kizuka H, Kusaba K, Sano H, Nishioka A, Shindo T, Kubota Y, Ando T, Kojima K, Kimura S.
Paraneoplastic sarcoidosis in multiple myeloma;　2017 ANNOUNCEMENT INFO.;　Intern Med., 56, 15, 2049-2051 AUTHOR;　Kusaba K, Kojima K, Naito S, Taba M, Kai K, Ureshino H, Nishida Y, Kimura S
Rituximab-induced Acute Thrombocytopenia in High Tumor Burden Follicular Lymphoma;　2016 ANNOUNCEMENT INFO.;　Intern Med., 55, 15, 2061-4 AUTHOR;　Ureshino H, Nishioka A, Kojima K, Suzuki M, Kizuka H, Sano H, Shindo T, Kubota Y, Ando T, Kimura S.
Acute Megakaryoblastic Leukemia with Myelodysplasia-related Changes Associated with ATM Gene Deletion.;　2016 ANNOUNCEMENT INFO.;　Intern Med., 55, 12, 1625-9 AUTHOR;　Ureshino H, Tanabe M, Kurogi K, Miyahara M, Kimura S
Subdural hematoma associated with dasatinib and intrathecal methotrexate treatment in Philadelphia chromosome-positive acute lymphoblastic leukemia.;　2016 ANNOUNCEMENT INFO.;　Intern Med., 55, 18, 2703-6 AUTHOR;　Ureshino H, Nishioka A, Kojima K, Kizuka H, Sano H, Shindo T, Kubota Y, Ando T, Kimura S.
Coexistence of lung cancer and immunoglobulin G4-related lung disease in a nodule: a case report.;　2016 ANNOUNCEMENT INFO.;　J Med Case Rep., 10, 1, 113 AUTHOR;　Tashiro H, Takahashi K, Nakamura T, Komiya K, Kimura S. Sueoka-Aragane N.
Chronic and Asymptomatic Diffuse Alveolar Haemorrhage with Microscopic Polyangiitis: A Case Report and Review of the Literature.;　2016 ANNOUNCEMENT INFO.;　Case Rep Rheumatol., 2016, 1658126 AUTHOR;　Tashiro H, Takahashi K, Sadamatsu H, Uchida M, Kimura S, Sueoka-Aragane N
Reversible Liver Steatosis Induced by Chemotherapy of Mixed-phenotype Acute Leukemia;　2016 ANNOUNCEMENT INFO.;　Intern Med, 55, 8, 1025-1026 AUTHOR;　Nishioka A, Kubota Y, Sueoka E, Kimura S.
Acute myeloid leukemia with t(3;8)(q26;q24) complicated by diabetes insipidus.;　2016 ANNOUNCEMENT INFO.;　Ann Hematol., 95, 4, 653-5 AUTHOR;　Kubota Y, Ichinohe T, Yoshimura M, Itamura H, Hisatomi T, Fukushima N, Sueoka E, Kimura S.
Domino-style cerebral bleeding in immune thrombocytopenic purpura.;　2016 ANNOUNCEMENT INFO.;　JAMA Neurol., 73, 4, 474-5 AUTHOR;　Kitamura H, Shindo T, Yakushiji Y, Yoshihara M, Eriguchi M, Kubota Y, Noguchi T, Kimura S.
Famotidine-induced reactive plasmacytosis and generalized lymphadenopathy: a case report and review of the literature.;　2016 ANNOUNCEMENT INFO.;　Int J Clin Exp Pathol, 9, 7, 7680-7685 AUTHOR;　Kitamura H, Kubota Y, Fukushima N, Ichinohe T, Hayasaka D, Kamachi K, Yoshihara M, Itamura H, Hisatomi T, Wakayama K, Sueoka E, Kimura S.
Hairy cell leukemia with systemic lymphadenopathy: Detection of BRAF mutation in a lymph node specimen.;　2015 ANNOUNCEMENT INFO.;　Intern Med., 54, 11, 1397-402 AUTHOR;　Okada K, Kunitomi A, Sakai K, Muramushi H, Okamoto Y, Tsukamoto T, Sugiura H, Matsui H, Jo T, Ueda T, Onishi T, Takizawa J, Aoki S, Ide M, Kimura S
A case of relapsing polychondritis successfully treated with combination of a glucocorticoid and cyclosporine.;　2015 ANNOUNCEMENT INFO.;　Int J Clin Med, 6, 7, PP. 439-443 AUTHOR;　Takahashi K, Inoue H, Sadamatsu H, Umeguchi H, Sueoka-Aragane N, Kimura S
Rituximab-containing chemotherapy (R-CHOP)-induced Kaposi’s sarcoma in an HIV-negative patient with diffuse large B cell lymphoma.;　2015 ANNOUNCEMENT INFO.;　Intern Med., 54, 24, 3205-8 AUTHOR;　Ureshino H, Ando T, Kojima K, Itamura H, Jinnnai S, Doi Kazuko, Oshima K, Kurogi K, Miyahara M, Kimura S.
Spontaneous regression of methotrexate related lymphoproliferative disorder with T cell large granular lymphocytosis.;　2015 ANNOUNCEMENT INFO.;　Intern Med., 54, 17, 2235-9 AUTHOR;　Ureshino H, Kadota C, Kurogi K, Miyahara M, Kimura S
Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia.;　2015 ANNOUNCEMENT INFO.;　Int J Hematol., 102, 3, 379-82 AUTHOR;　Ando T, Kojima K, Isoda H, Eguchi Y, Honda T, Ishigami M, Kimura S
Coexistence of ALK- anaplastic large cell lymphoma and CD4+ T cell large granular lymphocytic leukemia.;　2015 ANNOUNCEMENT INFO.;　Ann Hematol., 94, 3, 539-40 AUTHOR;　Kamachi K, Fukushima N, Ando T, Sato K, Ohshima K, Yokoo M, Shindo T, Kubota Y, Kojima K, Kimura S

General Lectures

The presence and possible role of virus-host chimeric transcripts in adult T-cell leukemia-lymphoma.;　2019 ANNOUNCEMENT INFO.;　ASH2019, 2019, 12, 7-10 AUTHOR;　Katsuya H, Miyazato P, Islam S, Tan BJY, Inada Y, Matsuo M, Ueno T, Tokunaga M, Hata H, Yamagishi M, Fujisawa J, Watanabe T, Uchimaru K, Utsunomiya A, Kimura S, Satou Y.
An effect of novel non-antibiotic macrolide EM900 in HDM-induced airway inflammation mice model;　2019 ANNOUNCEMENT INFO.;　ATS2019, 2019, 5, 17-22 AUTHOR;　Sadamatsu H, Takahashi K, Tashiro H, Noguchi Y, ?mura S, Kimura S, Sunazuka T, Sueoka-Aragane N
Characteristics of circulating tumor DNA in lung cancer patients. ;　2018 ANNOUNCEMENT INFO.;　AACR Annual Meeting 2018, 2018, 4,14-18 AUTHOR;　Abe T, Nakashima C, Sato A, Sueoka E, Kimura S, Sueoka-Aragane N
Evaluation of low level detection of major BCR-ABL1 mRNA in chronic myeloid leukemia (DOMEST additional study);　2018 ANNOUNCEMENT INFO.;　23rd Congress of EHA, 2018, 6, 14-17 AUTHOR;　Hiroaki Kitamura,Yoko Tabe, Koji Tsuchiya, Maiko Yuri, Shigeki Misawa, Takashi Horii, Akimichi Ohsaka, Shinya Kimura
irAE, Possible Predictive Markers for Immune Checkpoint Inhibitors;　2018 ANNOUNCEMENT INFO.;　IASLC 19th WORLD CONFERENCE ON LUNG CANCER, 2018, 9,23-26 AUTHOR;　Kazutoshi Komiya, Tomomi Nakamura, Haruki Hirakawa, Shinsuke Ogusu, Chiho Nakashima, Koichiro Takahashi, Shinya Kimura, Naoko Sueoka-Aragane.
Mechanisms of acquired resistance to afatinib clarified with liquid biopsy;　2018 ANNOUNCEMENT INFO.;　IASLC 19th WORLD CONFERENCE ON LUNG CANCER, 2018, 9,23-26 AUTHOR;　Tomomi Nakamura, Chiho Nakashima, Kazutoshi Komiya, Kimura S, Sueoka-Aragane N
Investigation of origin of circulating free DNA: Is exosomal DNA the carrier?;　2018 ANNOUNCEMENT INFO.;　AACR Annual Meeting 2018, 2018, 4,14-18 AUTHOR;　Nakashima C, Abe T, Sato A, Nakamura T, Komiya K, Sueoka E, Kimura S, Sueoka-Aragane N
Investigation of origin of circulating free DNA: Is EV the carrier? ;　2018 ANNOUNCEMENT INFO.;　The 14th Japan-Korea Joint Symposium on Cancer and Ageing Research, 2018, 5, 31- 6,2 AUTHOR;　Nakashima C, Sato A, Abe T, Nakamura T, Komiya K, Sueoka E, Kimura S, Sueoka-Aragane N
An Effect of Clarthromycin Treatment in HDM-Induced Allergic Airway Inflammation in Mice;　2018 ANNOUNCEMENT INFO.;　ATS 2018, 2018, 5, 18-23 AUTHOR;　Sadamatsu H, Takahashi K, Tashiro H, Kato G, Uchida M, Kimura S, Sueoka-Aragane N.
Characteristics of circulating free DNA in lung cancer patients. ;　2018 ANNOUNCEMENT INFO.;　The 77th Annual Meeting of the Japanese Cancer Association, 2018, 9, 27-29 AUTHOR;　Tomonori Abe, Chiho Nakashima, Akemi Sato, Yohei Harada, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane.
Analysis of a novel mutation of ERBB2 in cancer of unknown primary;　2018 ANNOUNCEMENT INFO.;　The 77th Annual Meeting of the Japanese Cancer Association, 2018, 9, 27-29 AUTHOR;　
Investigation of origin of circulating free DNA: Are extracellular vesicles the carrier?;　2018 ANNOUNCEMENT INFO.;　The 77th Annual Meeting of the Japanese Cancer Association, 2018, 9, 27-29 AUTHOR;　Chiho Nakashima, Tomonori Abe, Yohei Harada, Akemi Sato, Tomomi Nakamura, Kazutoshi Komiya, Eisaburo Sueoka, Shinya Kimura, Naoko Sueoka-Aragane
Characteristics of cell free DNA in lung cancer patients.;　2017 ANNOUNCEMENT INFO.;　IASLC 18th WORLD CONFERENCE ON LUNG CANCER., 2017,10,15-18 AUTHOR;　Tomonori Abe, Chiho Nakashima, Akemi Sato, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane.
Characteristics of cell free DNA in lung cancer patients.;　2017 ANNOUNCEMENT INFO.;　The 76th Annual Meeting of the Japanese Cancer Association, 2017.9.28-30 AUTHOR;　Tomonori Abe, Chiho Nakashima, Naomi Watanabe, Akemi Sato, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane.
Allelic polymorphisms of KIR and HLA predict favorable responses to TKIs in CML patients. 19th Annual John Goldman Conference on Chronic Myeloid Leukemia: ;　2017 ANNOUNCEMENT INFO.;　19th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy, 2017,10,12-15 AUTHOR;　Kimura S.
Downregulation of BMI-1 by the small molecule PTC596 induces mitochondrial apoptosis in mantle cell lymphoma;　2017 ANNOUNCEMENT INFO.;　59th ASH Annual Meeting & Exposition, 2017, 12, 9-12 AUTHOR;　Kojima K, Maeda A, Okamoto A, Nishida Y, Liangl C, Weetall M, Branstrom A, Kimura S
Correlation and problems of re-biopsy and liquid biopsy for detecting T790M mutation.;　2017 ANNOUNCEMENT INFO.;　IASLC 18th WORLD CONFERENCE ON LUNG CANCER., 2017,10,15-18 AUTHOR;　Kazutoshi Komiya, Tomomi Nakamura, Momoko Hayase, Haruki Hirakawa, Shinsuke Ogusu, Tomonori Abe, Chiho Nakashima, Koichiro Takahashi, Yuji Takeda, Kimura S, Sueoka-Aragane N.
Clarification of mechanisms of acquired resistance for afatinib using plasma samples.;　2017 ANNOUNCEMENT INFO.;　IASLC 18th WORLD CONFERENCE ON LUNG CANCER., 2017,10,15-18 AUTHOR;　Tomomi Nakamura, Chiho Nakashima, Kazutoshi Komiya, Kimura S, Sueoka-Aragane N.
DNA extraction method using cellulose magnetic beads can improve the EGFR mutation detection rate.;　2017 ANNOUNCEMENT INFO.;　The 76th Annual Meeting of the Japanese Cancer Association, 2017.9.28-30 AUTHOR;　Chiho Nakashima, Tomonori Abe, Akemi Sato, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane
Automatic Digital Quantification of Bone Marrow Myeloma Volume in Appendicular Skeletons ? Clinical Implications and Prognostic Significance;　2017 ANNOUNCEMENT INFO.;　59th ASH Annual Meeting & Exposition, 2017, 12, 9-12 AUTHOR;　Nishida Y, Kimura S, Mizobe H, Yamamichi J, Kojima K, Kawaguchi A, Fujisawa M, Matsue K
Recruited lung macrophages contribute to progression of airway inflammation in obesity asthma mice model. ;　2017 ANNOUNCEMENT INFO.;　American Thoracic Society 2017 International Conference, May 19-24, 2017, Washington, D.C. AUTHOR;　Hiroki Tashiro, Hironori Sadamatsu, Koichiro Takahashi, Go Kato, Shinya Kimura, Naoko Sueoka-Aragane.
IMPACT OF KIR3DL1*00501 IN TYROSINE KINASE INHIBITOR-TREATED CML;　2017 ANNOUNCEMENT INFO.;　22nd Congress of EHA, 2017, 6, 22-25 AUTHOR;　Hiroshi Ureshino , Takero Shindo, Yasushi Kusunoki , Yuki Miyazaki , Hiroto Kojima , Hidenori Tanaka , Hiroh Saji , Atsushi Kawaguchi , Shinya Kimura
IL-33 from inflammatory monocytes recruited to lung contributes to HDM-Induced airway inflammation;　2016 ANNOUNCEMENT INFO.;　The 65th Annual Meeting of Japanese Society of Allergology (English oral session), 2016.6.17-19 AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Go Kato, Shinichiro Hayashi, Shinya Kimura, Naoko Sueoka-Aragane
Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer;　2016 ANNOUNCEMENT INFO.;　AACR Annual Meeting 2016, 2016 April 16-20 AUTHOR;　Watanabe-Kobayashi N, Sato A, Watanabe T, Sueoka E, Kimura S, Sueoka-Aragane N
IL-33 from inflammatory monocytes recruited to lung contributes to HDM-Induced airway inflammation;　2016 ANNOUNCEMENT INFO.;　ATS International Conference 2016, 2016, May, 13-18 AUTHOR;　H. Tashiro, K. Takahashi, G. Kato, S. Hayashi, S. Kimura, N. Sueoka-Aragane
Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer;　2016 ANNOUNCEMENT INFO.;　The 75th Annual Meeting of the Japanese Cancer Association, October 6-8, 2016 AUTHOR;　Naoko Sueoka-Aragane, Naomi Watanabe, Akemi Sato, Tatsuro Watanabe, Eisaburo Sueoka, Shinya Kimura
Investigation of mechanism of lymphogenous metastasis using human lung cancer metastatic animal model;　2016 ANNOUNCEMENT INFO.;　The 75th Annual Meeting of the Japanese Cancer Association, October 6-8, 2016 AUTHOR;　Chiho Nakashima, Akemi Sato, Shinya Kimura, Naoko Aragane
A retrospective analysis of the efficacy and safety of ALK inhibitors in ALK-positive lung cancer patients;　2016 ANNOUNCEMENT INFO.;　IASLC 17th WORLD CONFERENCE ON LUNG CANCER, 2016.12.4-7 AUTHOR;　Komiya K, Nakamura T, Kurihara Y, Hirakawa H, Sadamatsu H, Nakashima C, Umeguchi H, Takeda Y, Kimura S, Sueoka-Aragane N
A case with cancer of unknown primary diagnosed pathologically retroperitoneal squamous cell carcinoma.;　2015 ANNOUNCEMENT INFO.;　The Japanese Society of Medical Oncology 2015 Annual Meeting, 2015.7.16-18 AUTHOR;　Hiroaki Kitamura, Tomomi Kashiwada, Kazutoshi Komiya, YukihikoNakayma, Takahiko Nakazono, Yukari Takase, Naoko Aragane, Shinya Kimura
Monocytes IL-33 contributes to HDM-induced allergic airway inflammation;　2015 ANNOUNCEMENT INFO.;　American Thoracic Society 2015 International Conference in Denver, 2015, 5, 15-20 AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Go Kato, Naoko Sueoka-Aragane, Shinya Kimura ,Shinichiro Hayashi
The MEK inhibitor trametinib selectively suppresses GVHD, while sparing GVT effects.;　2015 ANNOUNCEMENT INFO.;　2015 BMT Tandem Meetings, 2015,2,11-15 AUTHOR;　Itamura H, Shindo T, Tawara I, Kariya R, Okada S, Komanduri KV, Kimura S
The MEK inhibitior Trametinib selectively suppresses Graft-versus-Host Disease (GVHD), while sparing Graft-versus-Tumor (GVT) effects.;　2015 ANNOUNCEMENT INFO.;　 AUTHOR;　Itamura H, Shindo T, Kubota Y, Kimura S
SPARC, a possible predictive marker to albumin-bound paclitaxel (nab-paclitaxel) in non-small cell lung cancer;　2015 ANNOUNCEMENT INFO.;　16th World Conference on Lung Cancer, 2015.9.6-9 AUTHOR;　Kazutoshi Komiya, Tomomi Nakamura, Hironori Sadamatsu, Chiho Nakashima, Koichiro Takahashi, Hitomi Umeguchi, Naomi Kobayashi, Akemi Sato, ○Yuji Takeda, Shinya Kimura, Naoko Sueoka-Aragane
Potential predictive markers for re-challenge with first generation and second generation EGFR-TKI;　2015 ANNOUNCEMENT INFO.;　16th World Conference on Lung Cancer, 2015.9.6-9 AUTHOR;　Tomomi Nakamura, Akemi Sato, Naomi Kobayashi, Hitomi Umeguchi, Kazutoshi Komiya, Shinya Kimura, Naoko Aragane
Clinical features and treatment outcomes of acute erythroid leukemia in the last decade;　2015 ANNOUNCEMENT INFO.;　 AUTHOR;　Nishioka A, Kubota Y, Yamaguchi K, Kamachi K, Kitamura H, Yokoo M, Shindo T, Ando T, Kojima K, Sueoka E, Kimura S
A case with cancer of unknown primary diagnosed pathologically retroperitoneal squamous cell carcinoma.;　2014 ANNOUNCEMENT INFO.;　73th Annual Meeting of the Japanese Cancer Association, 2014.9.25-27 AUTHOR;　Hiroaki Kitamura, Tomomi Kashiwada, Kazutoshi Komiya, YukihikoNakayma, Takahiko Nakazono, Yukari Takase, Naoko Aragane, Shinya Kimura
Volume-based response evaluations with consensual lesion selection using cloud solutions in clinical trials: a pilot study;　2014 ANNOUNCEMENT INFO.;　2014 ASCO Annual Meeting, May 30 – June 3, 2014 AUTHOR;　Estanislao Oubel, Eric Bonnard, Sueoka-Aragane N, Kobayashi N, C.Charbonnier, Yamamichi J, Mizobe H, Kimura S
Efficacy and toxicity of mogamulizumab for relapsed/refractory adult T-cell leukemia-lymphoma: a retrospective analysis in Saga prefecture, Japan;　2014 ANNOUNCEMENT INFO.;　The 19th European Hematology Association Congress, June 12－15, 2014 AUTHOR;　Kamachi K, Kubota Y, Ureshino H, Miyahara M, Yoshihara M, Kitamura H, Ide M, Shindo T, Ando T, Kojima K, Sueoka E, Kimura S
2-Hydroxypropyl-β-cyclodextrin acts as a novel anticancer agent. ;　2014 ANNOUNCEMENT INFO.;　The 19th European Hematology Association Congress, June 12－15, 2014 AUTHOR;　Kubota Y, Yokoo M, Motoyama K, Higashi T, Taniyoshi M, Tokumaru H, Tabe Y, Mochinaga S, Sato A, Sueoka-Aragane N, Sueoka E, Arima H, Irie T, Kimura S
Usefulness of peripheral blood for monitoring of acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer;　2014 ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting 2014, April 5-9, 2014 AUTHOR;　Kobayashi N,Sueoka-Aragane N,Umeguchi H,Nakamura T,Sato A,Komiya K, Takeda Y,Hayashi S, Sueoka E, Kimura S
Monitoring of metastasis by detection of EGFR mutation, T790M, with plasma using animal model for metastasis of human lung cancer;　2014 ANNOUNCEMENT INFO.;　2014 ASCO Annual Meeting, May 30 – June 3, 2014 AUTHOR;　Sueoka-Aragane N,Katakami N, Satouchi M, Yokota S, Aoe K, Iwanaga K, Otsuka K,Kimura S, Negoro S
Non-invasive monitoring system for acquired resistance to EGFR-tyrosine kinase inhibitors using circulating plasma DNA;　2014 ANNOUNCEMENT INFO.;　The 73th Annual Meeting of the Japanese Cancer Association, September 25-27, 2014 AUTHOR;　Sueoka-Aragane N,Nakamura T,Sato A,Kobayashi N,Iwanaga K,Komiya K, Hosomi T, Hirai M,Sueoka E,Okada S,Kimura S
Monitoring of EGFR T790M with plasma in lung cancer patients;　2014 ANNOUNCEMENT INFO.;　ESMO 2014 Congress, September 26-30, 2014. AUTHOR;　Urata Y,Sueoka-Aragane N, Katakami N, Satouchi M,Yokota S, Aoe K, Iwanaga K, Otsuka K, KimuraS,Negoro S
Ⅲ (EFM) patient with rare genotype expressing anti-E antibody after transfusion of platelet concentrates;　2014 ANNOUNCEMENT INFO.;　AABB Annual Meeting 2014, October 25-28, 2014 AUTHOR;　〇Yamada M, Yamada N, Kon N, Miyazaki T, Ohasi W, Sato S, Higasitani T, Kubota Y, Takamoto S, Kimura S, Sueoka E. A partial E
Anti-proliferative effect of 2-hydroxypropyl-β-cyclodextrin against chronic myeloid leukemia;　2014 ANNOUNCEMENT INFO.;　Saga and NUS joint meeting for CyD, 2014.3.28 AUTHOR;　Yokoo M, Kubota Y, Kimura S
Low-dose dasatinib treatment for elderly CML patients;　2014 ANNOUNCEMENT INFO.;　 AUTHOR;　Itamura H, Kamachi K, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Kimura S
Two cases of meningeal infiltration with adult T cell leukemia/lymphoma after mogamulizumab treatment;　2014 ANNOUNCEMENT INFO.;　 AUTHOR;　Kamachi K, Yasushi Kubota Y, Nishioka A, Yamuguchi K, Kitamura H, Yokoo M, Shindo T, Ando T, Kojima K, Kimura S
Three cases of hemodialysis patients with advanced gastric cancer treated with Paclitaxel and nab paclitaxel;　2014 ANNOUNCEMENT INFO.;　 AUTHOR;　Kashiwada　T、Aragane　N、Kimura　S
Diffuse bone marrow uptake of FDG in a patient with aleukemic acute lymphoblastic leukemia;　2014 ANNOUNCEMENT INFO.;　The 5th JSH International Symposium 2014, 2014,5,24-25 AUTHOR;　Kitamura H,Ando T,Kojima K,Kamachi K,Yoshihara M,Shindo T,Kubota Y,Komiya K,Sueoka-Aragane N, Sueoka E, Kimura S
Two cases of immune thrombocytopenic purpura with multiple cerebral microbleeds;　2014 ANNOUNCEMENT INFO.;　 AUTHOR;　Kitamura H,Yoshihara M,Kamachi K,Eriguchi M, Noguchi T,Kubota Y,Shindo T,Ando T,Sueoka E,Kojima K,Kimura S
Usefulness of peripheral blood for monitoring of acquired resistance to EGFR tyrosine kinase inhibitors.;　2014 ANNOUNCEMENT INFO.;　第73回日本癌学会学術集会総会, 2014.9.25-27 AUTHOR;　Kobayashi N, Sueoka-Aragane N, Nakamura T, Sato A, Komiya K, Sueoka E, Kimura S
SPARC, as a possible predictive marker for albumin-bound paclitaxel in non-small cell lung cancer;　2014 ANNOUNCEMENT INFO.;　The 73th Annual Meeting of the Japanese Cancer Association, September 25-27, 2014 AUTHOR;　Komiya K, Sueoka-Aragane N, Kobayashi N, Sato A, Nakamura T, Hayash S,Kimura S
2-Hydroxypropyl-β-cyclodextrin acts as a novel anticancer agent.;　2014 ANNOUNCEMENT INFO.;　第76回日本血液学会学術集会, 2014.10.31-11.2 AUTHOR;　Kubota Y, Yokoo M, Motoyama K, Higashi T, Taniyoshi M, Tokumaru H, Tabe Y, Sueoka E, Arima H, Irie T, Kimura S
Small lymphocytic lymphoma presenting as bulky renal incidentaloma;　2014 ANNOUNCEMENT INFO.;　第76回日本血液学会学術集会, 2014.10.31-11.2 AUTHOR;　○Kusano S,Kamachi K, Kojima K, Kitamura H, Shindo T, Kubota Y, Ando T, Kimura S
Correlation between plasma DNA and tumor status in an animal model on metastasis of lung cancer;　2014 ANNOUNCEMENT INFO.;　The 73th Annual Meeting of the Japanese Cancer Association, September 25-27, 2014 AUTHOR;　Sato A,Sueoka-Aragane N, Kobayashi N,Nagano Y,Sueoka E,Okada S,Kimura S
Brainstem Encephalitis with anti-ganglioside antibody associated with mogamulizumab treatment;　2014 ANNOUNCEMENT INFO.;　第76回日本血液学会学術集会, 2014.10.31-11.2 AUTHOR;　Ureshino H, Shindo T, Miyahara M, Nishikawa H, Sakaguchi S, Samukawa M, Kusunoki S,Kimura S
Induction of p53 Transcription and Apotosis by XPO1 Inhibition in Mantle Cell Lymphoma.;　2013 ANNOUNCEMENT INFO.;　The 55th Annual Meeting of the American Society of Hematology, 2013.12.7-10 AUTHOR;　Yoshimura M, Ishizawa J, Dilip A, Ruvolo V, Quintas-Cardama A, McDonnell TJ, Neelapu SS, Kwak LW, Shachem S, kauffman M, Tabe Y, Yokoo M, Kimura S, Andreeff M, Kojima K
Establishment of animal model for metastasis of human lung cancers using NOJ/SCID mice.;　2013 ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting 2013, April 6-10 AUTHOR;　Naoko Aragane, Akemi Sato, Naomi Kobayashi, Masaru Ide, Eisaburo Sueoka, Seiji Okada, Shinya Kimura.
Establishment of a rapid and automated detection system for BRAF mutations in malignant melanoma.;　2013 ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting 2013, April 6-10, 2013 AUTHOR;　Masaru Ide, Shinichi Koba, Yumi Nagano, Naoko Aragane-Sueoka, Akemi Sato, Takuya Inoue, Naomi Kobayashi, Noriyuki Misago, Yutaka Narisawa, Shinya Kimura, Eisaburo Sueoka.
Non-invasive monitoring system using circulating plasma DNA;　2013 ANNOUNCEMENT INFO.;　The 72th Annual Meeting of the Japanese Cancer Association, October 3-5 AUTHOR;　Naoko Aragane, Tomomi Nakamura, Akemi Sato, Naomi Kobayashi, Kentaro Iwanaga, Kazutoshi Komiya, Toshiya Hosomi, Mitsuharu Hirai, Eisaburo Sueoka, Seiji Okada, Shinya Kimura.
A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids;　2013 ANNOUNCEMENT INFO.;　European Respiratory Society, International Congress 2013 in Barcelona, 2013. 9.7 - 11 AUTHOR;　Koichiro Takahashi, Go Kato, Shinya Kimura and Shinichiro Hayashi
Deferasirox in iron-overloaded patients with hematologic diseases at Saga University Hospital;　2013 ANNOUNCEMENT INFO.;　 AUTHOR;　○Abe O, Yoshihara M, Kubota Y, Sueoka E, Kamachi K, Kitamura H, Itamura H, Nishi M, Shindo T, Fukushima N, Hamasaki Y, Kimura S
Therapeutic management in cardiac lymphoma;　2013 ANNOUNCEMENT INFO.;　 AUTHOR;　Yoshihara M, Itamura H, Fukushima N, Kamach K, Kitamura H, Shindo T, Kubota Y, Sueoka E, Ichinohe T, Kimura S

Review Articles

Development status of new therapeutic agents for CML;　2019/05 ANNOUNCEMENT INFO.;　Hematology, 78, 5, 657 - 663 AUTHOR;　Kimura Shinya
Evaluation of CML therapy by tyrosine kinase inhibiters and possibility of stop them;　2019/01 ANNOUNCEMENT INFO.;　, 268, 1, 67 - 71 AUTHOR;　Kusaba Kana, KImura Shinya
Epigenetic abnormalities as a therapeutic target in adult T-cell leukemia-lymphoma;　2019/01 ANNOUNCEMENT INFO.;　Hematology, 78, 1, 117 - 121 AUTHOR;　○Watanabe Tatsuro, Kimura Shinya
The Current State of Therapeutic Development for Rare Cancers in Japan, and Proposals for Improvement.;　2018 ANNOUNCEMENT INFO.;　Cancer Sci. , 109, 5, 1731-1737 AUTHOR;　*Kawai A, Goto T, Shibata T, Tani K, MizutaniS, Nishikawa A, Shibata T, Matsumoto S, Nagata K, Narukawa M, Matsui S, Ando M, Toguchida J, Monden M, Heika T, Kimura S, Ueda R
Current status of ABL tyrosine kinase inhibitors stop studies for chronic myeloid leukemia;　2016 ANNOUNCEMENT INFO.;　Stem Cell Investig., http://sci.amegroups.com/article/view/11261/11838, 3, 36 AUTHOR;　Kimura S.
Ever-advancing chronic myeloid leukemia treatment;　2014 ANNOUNCEMENT INFO.;　Int J Clin Oncol. , 19, 1, 3-9 AUTHOR;　Kimura S, Ando T, Kojima K

Invited Lecture, Special Lecture

ABL Tyrosine Kinase Inhibitors and Minimal Residual Disease Negativity during Treatment and Stop ;　2018 ANNOUNCEMENT INFO.;　Anti-Cancer Treatment Japan, 2018, 5,18-19 AUTHOR;　Kimura S
Molecular target therapy and new technologies;　2016 ANNOUNCEMENT INFO.;　8th International Workshop on Advanced Materials Science and Nanotechnology ( IWAMSN 2016), 2016.11.8-12 AUTHOR;　Kimura S
Exploring the Anti-tumor Mechanisms of Zoledronic acid.;　2010/09 ANNOUNCEMENT INFO.;　Taiwan Breast Cancer Clinical and Basic Seminar. AUTHOR;　Kimura S
Anticancer effects of bisphosphonates: Pre-clinical Outlook.;　2010/07 ANNOUNCEMENT INFO.;　Breast cancer 18th Opinion Leader Summit, AUTHOR;　Kimura S.
Role of TKIs in CML;　2010/06 ANNOUNCEMENT INFO.;　KSH-JSH joint Meeting. AUTHOR;　Kimura S.
Activity of the Multi-targeted Kinase Inhibitor, AT9283 on Imatinib-Resistant CML Models;　2009/09 ANNOUNCEMENT INFO.;　ESH Eleventh International Conference on CML AUTHOR;　Kimura S, Tanaka R, Matthew S Squires3, Yokota A, Kirsty Mallett, Matthias Reule , Tomoko Smyth, Neil T Thompson, Nagao R, Yamauchi T, Ashihara E, John F Lyons, Maekawa T
Lesson from CML, molecular targets in myeloid leukemias.;　2009/03 ANNOUNCEMENT INFO.;　6th Korean Society of Hematology AML/MDS Working Party Symposium, 3rd Korean-Japan Joint Symposium on "Molecular Targets and AML/MDS Therapeutics AUTHOR;　Kimura S
Exploring the antitumor mechanisms of bisphosphonates in clinic. Modulating the immune response. 　;　2009/01 ANNOUNCEMENT INFO.;　ZENITH Meeting. AUTHOR;　Kimura S

Mentors

Mentees

Colleagues

{{memberType.MembershipTypeTitle}} of

{{group.Title}} ({{group.GroupName}})

{{membership.Description}}

Administrations

{{administration.Title}}
- {{subEvent.Title}} ({{subEvent.Code}}) {{subEvent.Administrators[0].UASCredit}} UAS
  
  Role: {{subEvent.Administrators[0].RoleTitle}} Position: {{subEvent.Administrators[0].Position}}

Participated

{{mainEvent.Title}}
- {{subEvent.Title}} ({{subEvent.Code}}) {{subEvent.UASCredit}} UAS

{{model.ShownName}}

Nobel Laureate Abel Laureate Advisory Board Member USERN President USERN Policy Making Council USERN Manager USERN Deputy Junior Ambassador

{{group.Title}} ({{group.GroupName}})

{{administration.Title}}

{{subEvent.Title}} ({{subEvent.Code}}) {{subEvent.Administrators[0].UASCredit}} UAS

Role: {{subEvent.Administrators[0].RoleTitle}} Position: {{subEvent.Administrators[0].Position}}

{{mainEvent.Title}}

{{subEvent.Title}} ({{subEvent.Code}}) {{subEvent.UASCredit}} UAS